To investigate the selective effect of EB-42168 relative to MLi-2 on LRRK2 phosphorylation and mtDNA damage biomarkers in PD patient cells, LRRK2 G2019S and healthy control-derived lymphoblastoid cells (LCLs) were evaluated. Here, LRRK2 is linked to Parkinson disease.